Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Eran OphirPresident and CEO | CompugenCGEN | Open-market sale10b5-1 plan | 04/24 | 04/27 | 5,000 sh | $3.20 | $16,000 | −30.5% |
Zurit LevineSVP, Business Development | CompugenCGEN | Open-market sale10b5-1 plan | 04/24 | 04/27 | 2,000 sh | $3.20 | $6,400 | −6.4% |
Eran OphirPresident and CEO | CompugenCGEN | Open-market sale10b5-1 plan | 04/14 | 04/15 | 5,000 sh | $2.90 | $14,500 | −30.5% |
CompugenCGEN | Open-market sale10b5-1 plan · Amendment | 04/10–04/14 | 04/15 | 5,125 sh2 trades | $2.65avg. | $13,600 | −14.9% | |
Zurit LevineSVP, Business Development | CompugenCGEN | Open-market sale10b5-1 plan | 04/10 | 04/13 | 3,125 sh | $2.56 | $8,000 | −9.6% |
CompugenCGEN | Open-market sale10b5-1 plan | 04/07–04/08 | 04/09 | 7,875 sh2 trades | $2.38avg. | $18,757.5 | −21.1% | |
Eran OphirPresident and CEO | CompugenCGEN | Open-market sale10b5-1 plan | 04/01 | 04/03 | 5,625 sh | $2.21 | $12,431.25 | −33.1% |
Zurit LevineSVP, Business Development | CompugenCGEN | Open-market sale10b5-1 plan | 04/01 | 04/03 | 3,500 sh | $2.20 | $7,700 | −10.6% |
Zurit LevineSVP, Business Development | CompugenCGEN | Open-market sale10b5-1 plan | 03/26 | 03/30 | 11,875 sh | $2.04 | $24,225 | −28.8% |